Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study

Overview of attention for article published in PLOS Medicine, December 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 24 news stories from 22 outlets.

Cause of Post-RP Death in High-Risk PCa Patients Linked to Age (HealthDay News) — Risk-tailored screening could potentially…

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for December 2019.

FRIDAY, Dec. 27, 2019 (HealthDay News) -- Risk-tailored screening could potentially reduce overdiagnosis and improve the cost-eff…

FRIDAY, Dec. 27, 2019 -- Risk-tailored screening could potentially reduce overdiagnosis and improve the cost-effectiveness of a…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 20 additional news stories.